Skip NavigationSkip to Content
Return Return to Search Results

Current prospects of type II interferon signaling and autoimmunity

  1. Author:
    Green, Daniel S.
    Young, Howard
    Valencia, Julio

  2. Author Address

    NCI, Womens Malignancy Branch, Translat Genom Sect, Ctr Canc,NIH, Bethesda, MD 20892 USA.NCI Frederick, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA.
    1. Year: 2017
    2. Date: Aug 25
  2. Journal: Journal of Biological Chemistry
  3. AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC,
    1. 292
    2. 34
    3. Pages: 13925-13933
  5. Type of Article: Article
  6. ISSN: 0021-9258
  1. Abstract:

    Interferon (IFN) is a pleiotropic protein secreted by immune cells. IFN signals through the IFN receptor, a protein complex that mediates downstream signaling events. Studies into IFN signaling have provided insight into the general concepts of receptor signaling, receptor internalization, regulation of distinct signaling pathways, and transcriptional regulation. Although IFN is the central mediator of the adaptive immune response to pathogens, it has been shown to be involved in several non-infectious physiological processes. This review will provide an introduction into IFN signaling biology and the functional roles of IFN in the autoimmune response.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1074/jbc.R116.774745
  3. PMID: 28652404
  4. PMCID: PMC5572907
  5. View record in Web of Science®
  6. WOS: 000408439800003

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel